lorazepam has been researched along with triazoles in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Barbhaiya, RH; Dockens, RC; Greene, DS; Kroboth, P; Salazar, DE | 1 |
| Barbhaiya, R; Chaikin, PC; Folan, MM; Kroboth, PD; Lush, RM; Salazar, DE; Shukla, UA | 1 |
| Agrawal, NG; Cohen, AF; de Haas, SL; de Smet, M; de Visser, SJ; Goel, TV; Hesney, M; Li, S; Murphy, MG; Pearson, LK; Rijnbeek, B; Schoemaker, RC; Simpson, RC; van der Post, JP; van Gerven, JM; Vega, JM | 1 |
| Cohen, AF; de Haas, SL; de Smet, M; de Visser, SJ; Murphy, MG; Ramakrishnan, R; Schoemaker, RC; van der Post, JP; van Dyck, K; van Gerven, JM; Vessey, LK; Xue, L | 1 |
| Ator, NA; Kohut, SJ | 1 |
| Atack, JR; Ator, NA; Burns, HD; Dawson, GR; Hargreaves, RJ | 1 |
| Einsele, H; Grau, A; Heinz, WJ; Helle-Beyersdorf, A; Klinker, H; Lenker, U; Schirmer, D; Ulrich, A; Zirkel, J | 1 |
| Horikoshi, S; Hoshino, H; Kanno, K; Miura, I; Ochiai, H; Osakabe, Y; Shiga, T; Yabe, H | 1 |
5 trial(s) available for lorazepam and triazoles
| Article | Year |
|---|---|
Coadministration of nefazodone and benzodiazepines: IV. A pharmacokinetic interaction study with lorazepam.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Humans; Lorazepam; Male; Piperazines; Triazoles | 1995 |
Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Arousal; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lorazepam; Male; Mental Recall; Metabolic Clearance Rate; Piperazines; Psychomotor Performance; Triazolam; Triazoles | 1995 |
Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.
Topics: Adult; Anti-Anxiety Agents; Area Under Curve; Blood Pressure; Cognition; Cross-Over Studies; Double-Blind Method; Electrocardiography; GABA-A Receptor Agonists; Heart Rate; Humans; Lorazepam; Male; Posture; Pyridazines; Saccades; Triazoles | 2007 |
Impact of benzodiazepines on posaconazole serum concentrations. A population-based pharmacokinetic study on drug interaction.
Topics: Anti-Anxiety Agents; Antifungal Agents; Benzodiazepines; Dose-Response Relationship, Drug; Drug Interactions; Humans; Lorazepam; Male; Retrospective Studies; Serum; Temazepam; Triazoles | 2012 |
Effects of benzodiazepine and orexin receptor antagonist on cognitive function revealed by auditory event-related potentials.
Topics: Adult; Auditory Perception; Azepines; Benzodiazepines; Cognitive Dysfunction; Discrimination, Psychological; Electroencephalography; Event-Related Potentials, P300; Evoked Potentials, Auditory; Female; Humans; Lorazepam; Male; Orexin Receptor Antagonists; Triazoles; Young Adult | 2021 |
3 other study(ies) available for lorazepam and triazoles
| Article | Year |
|---|---|
Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Cognition; Cross-Over Studies; Double-Blind Method; GABA-A Receptor Agonists; Humans; Lorazepam; Male; Pain Measurement; Pyridazines; Saccades; Triazoles | 2008 |
Novel discriminative stimulus effects of TPA023B, subtype-selective gamma-aminobutyric-acid(A)/benzodiazepine modulator: comparisons with zolpidem, lorazepam, and TPA023.
Topics: Animals; Ataxia; Conditioning, Operant; Data Interpretation, Statistical; Discrimination, Psychological; Dose-Response Relationship, Drug; GABA Agonists; GABA Modulators; Generalization, Psychological; Hypnotics and Sedatives; Lorazepam; Male; Psychomotor Performance; Pyridazines; Pyridines; Rats; Rats, Long-Evans; Receptors, GABA-A; Triazoles; Zolpidem | 2008 |
Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypes.
Topics: Animals; Behavior, Animal; Binding Sites; Brain; Dose-Response Relationship, Drug; GABA Agonists; GABA-A Receptor Agonists; Infusions, Intravenous; Injections, Intramuscular; Ligands; Lorazepam; Male; Molecular Structure; Papio; Positron-Emission Tomography; Protein Binding; Pyridazines; Self Administration; Structure-Activity Relationship; Substance-Related Disorders; Triazoles | 2010 |